Novo Nordisk and Eli Lilly currently control 99% of the market, but their dominance may weaken as new entrants introduce ...

Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

Days after suffering a rejection in Australia, the Alzheimer’s drug hit another roadblock in the U.K., which found the drug ...

In a randomized trial, Mass General Brigham researchers found the surgical removal of tonsils and adenoids was effective for children with snoring and ...

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

A combination, triplet therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in ...

Magnet Bio and Eli Lilly entered into a collaboration that could reach $1.25 billion in value. Cosette Pharmaceuticals agreed to purchase all outstanding Australia’s Mayne Pharma shares for $430 ...

Telix states its automated and high-throughput generator can produce sufficient lead-212 elution for up to 60 clinical doses, ...

A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the ...

Hong Kong-listed Innovent Biologics Inc. is considering a licensing partnership to develop a cancer drug that’s showing ...

These ETFs can add some stability to any portfolio. The post 3 defensive ETFs to navigate volatility on the ASX appeared ...